Estar Medical dba Medical Technologies, LTD

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Using TropoCells(R) Autologous Platelet-Rich Fibrin (PRF) to Treat Chronic Non-Healing Wounds	Wound Chronic Draining; Wound Closure	Not yet recruiting	Phase 2	2026-01-06		NCT07318792
Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care.	Diabetes Complications, Diabetic Foot, Foot Diseases, Foot Ulcer, Leg Ulcer, Nutritional and Metabolic Diseases, Skin Ulcer, Skin and Connective Tissue Diseases, autoimmune disease, cardiovascular disorder, diabetes mellitus, diabetic neuropathy, diabetic peripheral angiopathy, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, skin disorder, type 1 diabetes mellitus, type 2 diabetes mellitus, vascular disorder	Recruiting	Phase 2	2025-06-12		NCT06810726

Clinical trials